Biochem/physiol Actions Imidazoline agonist more potent than efaroxan in inducing insulin release from β cells H 1 histamine receptor antagonist. Features and Benefits This compound was developed by Novartis .
Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us
Imidazoline agonist; more potent than efaroxan in inducing insulin release from β cells; H1 histamine receptor antagonist.
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.
"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was
presently surprised by their product offering."
LAB DIRECTOR
"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."
PHARMACEUTICAL SUPPLY CHAIN LEADER
"The reps are very good at finding products for customers in this period of supply chain issues."
SCOTT BEHMAN
"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"
PROCUREMENT + BILLING COORDINATOR AT PHARMA.
